Health Care Utilization and Medicaid Spending in Children with Type 1 Diabetes in the Alabama Medicaid Program

Ransome Eke1, Xin Thomas Yang2, Kiersten L Bond1

  • 1Department of Health Science, The University of Alabama, Tuscaloosa, Alabama, USA.

Insights

Health service use and costs are higher for children with type 1 diabetes in Alabama

Area of Science:

  • Pediatric Endocrinology
  • Health Services Research
  • Health Economics

Background:

  • Limited data exist on healthcare utilization and costs for low-income children with type 1 diabetes.
  • Understanding these patterns is crucial for resource allocation and policy development.

Purpose of the Study:

  • To examine the patterns of healthcare service use and associated costs among low-income children with type 1 diabetes enrolled in Alabama's Medicaid program.
  • To identify factors influencing cost and service utilization in this population.

Main Methods:

  • Descriptive analysis of healthcare service utilization and costs.
  • Examination of demographic factors (race, age) influencing spending and utilization.
  • Analysis of data from the Alabama Medicaid program over a 7-year period.

Main Results:

  • Over 7 years, 5,638 children with type 1 diabetes were enrolled in Medicaid.
  • Direct medical costs for type 1 diabetes care increased substantially, outpacing overall Medicaid spending.
  • White children incurred higher costs and utilization than Black children; Hispanic children had the lowest costs.
  • Older children with type 1 diabetes exhibited significantly higher costs and utilization than younger children.

Conclusions:

  • Type 1 diabetes care for low-income children in Alabama incurs significant and rising costs within the Medicaid program.
  • Racial and age disparities exist in healthcare spending and service utilization for pediatric type 1 diabetes.
  • Further research is needed to address cost drivers and reduce disparities.

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.1K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
343
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.6K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
648
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.2K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
65